… of NLRP3 inflammasome activation, how dysregulation of NLRP3 inflammasome activation
causes disease, and potential therapeutics that inhibit NLRP3 inflammasome activation. …

… NLRP3 inflammasomes are of great importance to therapies targeting inflammation due
to their critical role in regulating inflammation. In many bacterial infections, pathogens …

… NLRP3 activation and regulation and highlight gaps in the understanding of activation
mechanisms. We discuss diseases in which overly active NLRP3 … are effective therapies in certain …

… with NLRP3 inflammasome … NLRP3 inflammasome signaling may represent a promising
therapeutic target for the treatment of neuroinflammation-associated neurological diseases…

… diseases. This review aims to summarise current literature on the role of the NLRP3
inflammasome in … Therapies targeting the NLRP3 inflammasome shouldn’t be disregarded for …

… NLRP3 inflammasome and its crucial role in the pathology of neurodegenerative disorders,
such as Alzheimer's disease, Parkinson's disease, … target the NLRP3 inflammasome pathway …

… (Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, … knowledge about the NLRP3
inflammasome role in these … and beneficial inflammasome so that new therapies can be …

… such as Alzheimer’s disease, atherosclerosis, metabolic … NLRP3 inflammasome complex
and its activation in disease, … We discuss the current therapies available and those under …

… Thus, NLRP3 inflammasome is a key molecule involved in the pathogenesis of … NLRP3
inflammasome-based targeted therapies for CVDs and the clinical evaluation of these therapies …

… regulatory mechanisms of the NLRP3 inflammasome in the pathogenic … NLRP3 inflammasome
for AD. Further clarification of the regulatory mechanisms of the NLRP3 inflammasome in …